JP2002516872A5 - - Google Patents

Download PDF

Info

Publication number
JP2002516872A5
JP2002516872A5 JP2000551795A JP2000551795A JP2002516872A5 JP 2002516872 A5 JP2002516872 A5 JP 2002516872A5 JP 2000551795 A JP2000551795 A JP 2000551795A JP 2000551795 A JP2000551795 A JP 2000551795A JP 2002516872 A5 JP2002516872 A5 JP 2002516872A5
Authority
JP
Japan
Prior art keywords
mrp
lys
trp
phe
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000551795A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002516872A (ja
Filing date
Publication date
Priority claimed from US09/089,955 external-priority patent/US5932548A/en
Application filed filed Critical
Publication of JP2002516872A publication Critical patent/JP2002516872A/ja
Publication of JP2002516872A5 publication Critical patent/JP2002516872A5/ja
Pending legal-status Critical Current

Links

JP2000551795A 1998-06-03 1999-05-28 心疾患の治療のためのリシン含有ペプチド Pending JP2002516872A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/089,955 1998-06-03
US09/089,955 US5932548A (en) 1998-06-03 1998-06-03 Lysine containing peptides for treatment of heart disease
PCT/EP1999/003731 WO1999062539A1 (en) 1998-06-03 1999-05-28 Lysine containing peptides for treatment of heart disease

Publications (2)

Publication Number Publication Date
JP2002516872A JP2002516872A (ja) 2002-06-11
JP2002516872A5 true JP2002516872A5 (cg-RX-API-DMAC7.html) 2006-07-06

Family

ID=22220375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000551795A Pending JP2002516872A (ja) 1998-06-03 1999-05-28 心疾患の治療のためのリシン含有ペプチド

Country Status (11)

Country Link
US (1) US5932548A (cg-RX-API-DMAC7.html)
EP (2) EP1082128B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002516872A (cg-RX-API-DMAC7.html)
AT (1) ATE314083T1 (cg-RX-API-DMAC7.html)
AU (1) AU4371799A (cg-RX-API-DMAC7.html)
CA (1) CA2330567A1 (cg-RX-API-DMAC7.html)
DE (1) DE69929188T2 (cg-RX-API-DMAC7.html)
DK (1) DK1082128T3 (cg-RX-API-DMAC7.html)
ES (1) ES2259834T3 (cg-RX-API-DMAC7.html)
PT (1) PT1082128E (cg-RX-API-DMAC7.html)
WO (1) WO1999062539A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
ATE348163T1 (de) 1998-10-23 2007-01-15 Amgen Inc Thrombopoietin substitute
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6211156B1 (en) * 1999-11-10 2001-04-03 Asta Medica A.G. Peptides for treatment of erectile dysfunction
JP3498041B2 (ja) 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
AU2001274601A1 (en) * 2000-06-23 2002-01-02 Kaken Pharmaceutical Co., Ltd. Preventives or remedies for heart failure
EP1417055A4 (en) * 2001-07-19 2007-09-26 Dmi Biosciences Inc USE OF COPPER CHELATORS TO PREVENT THE INACTIVATION OF PROTEIN C
TWI331922B (en) 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
AU2004238285A1 (en) * 2003-05-07 2004-11-25 Dmi Biosciences, Inc Oral care methods and products
CA2580796C (en) 2004-09-24 2013-03-26 Amgen Inc. Modified fc molecules having peptides inserted in internal loop regions
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
GB0603295D0 (en) 2006-02-18 2006-03-29 Ardana Bioscience Ltd Methods and kits
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
EP2021015A2 (en) * 2006-04-28 2009-02-11 The Administrators Of The Tulane Educational Fund Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
TW200916113A (en) * 2007-08-08 2009-04-16 Sod Conseils Rech Applic Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
GB2453116B (en) * 2007-09-25 2010-03-17 Medical & Pharm Ind Tech & Dev Uses of 2-[piperidinyl]methy1-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one in providing an analgesic effect
US8476408B2 (en) * 2008-06-13 2013-07-02 Alize Pharma Sas Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
EP2350118B1 (en) 2008-09-19 2016-03-30 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
RU2404793C1 (ru) 2009-06-04 2010-11-27 Общество с ограниченной ответственностью Био Пептид Стимулятор половой, сексуальной и репродуктивной функции
RU2507212C3 (ru) 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" Способ получения рекомбинантного пептида и полученный пептид
RU2626002C1 (ru) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" Новая группа пептидов для лечения женской сексуальной дисфункции

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668254A (en) * 1990-05-11 1997-09-16 Romano Deghenghi D-2-alkyl-tryptophan and peptides containing same
US5661122A (en) * 1994-04-15 1997-08-26 Genentech, Inc. Treatment of congestive heart failure
EP0783521B8 (en) * 1994-09-27 2003-04-09 Ardana Bioscience Limited Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
IT1277113B1 (it) * 1995-12-20 1997-11-04 Romano Deghenghi Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
SE9703929D0 (sv) * 1996-11-22 1997-10-28 Pharmacia & Upjohn Ab Therapeutical use and method
US5798102A (en) * 1997-03-04 1998-08-25 Milkhaus Laboratory, Inc. Treatment of cardiomyopathy
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.

Similar Documents

Publication Publication Date Title
JP2810240B2 (ja) サイトカイン調節剤およびサイトカインレベルの変化に関連する病状および状態における使用方法
JP4576493B2 (ja) 性機能障害の治療薬及び治療方法
ES2259834T3 (es) Peptidos que contienen lisina para el tratamiento de la enfermedad coronaria.
JP4177224B2 (ja) 胃切除術を受けた個体の低体重及び低体脂肪量を治療するためのグレリンの使用
JP2002504516A (ja) アンギオテンシンii型2リセプタ作用薬を含む医薬製剤およびその使用
Kondo et al. Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat
WO1990003980A1 (en) Therapeutic peptides
DE69533399T2 (de) Zyklische hexapeptid somatostatin analoga
JPH0689037B2 (ja) GnRH拮抗物質
US20020132779A1 (en) Analogs of L-Glu-L-Trp having pharmacological activity
JP2024532403A5 (cg-RX-API-DMAC7.html)
HUP0001431A2 (hu) Módosított tandem peptid, ezt tartalmazó immunogén gyógyászati készítmény és vakcina az LHRH hormon termelés ellen, és eljárás a sertéshús minőségének javítására
US6228373B1 (en) Peptides with immunomodulatory effects
MXPA04005712A (es) Composiciones que comprenden epotilonas y su uso para el tratamiento de sindrome carcinoide.
JP2003516417A5 (cg-RX-API-DMAC7.html)
US20080194470A1 (en) Nim811 In Cerebral Ischemia and Brain and Spinal Cord Injury
JP2002513801A5 (cg-RX-API-DMAC7.html)
WO1992009285A1 (en) Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections
WO1989009230A1 (en) Therapeutic peptides
JPH08502250A (ja) 成長ホルモン放出ペプチド
ITMI951670A1 (it) Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita
EP4203988A2 (en) Peptide inhibitors of nf kappa b and use thereof in treatment of covid-19 and inflammatory diseases
CA2385910A1 (en) Somatostatin analogs for the treatment of cancer
CA2163114A1 (en) Peptides exhibiting oxytocin antagonistic activity
US20110319329A1 (en) Use of somatostatin analogs in cluster headache